Rebus Holdings, Inc. (RBSH)

OTCMKTS: RBSH · Delayed Price · USD
0.0120
+0.0003 (2.56%)
Jun 5, 2023, 9:39 AM EDT - Market open
Market Cap 385.60K
Revenue (ttm) n/a
Net Income (ttm) -942,000
Shares Out 32.13M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,102
Open 0.0080
Previous Close 0.0117
Day's Range 0.0080 - 0.0120
52-Week Range 0.0050 - 0.0278
Beta -11.29
Analysts n/a
Price Target n/a
Earnings Date n/a

About RBSH

Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol RBSH
Full Company Profile

Financial Performance

Financial Statements

News

Inspyr Therapeutics Secures $500,000 to Support the Development of its Adenosine Pipeline

Proceeds support the development of lead asset, RT-AR001, an adenosine receptor antagonist Funds were secured from an existing institutional investor WESTLAKE VILLAGE, CA / ACCESSWIRE / January 12, 20...

2 years ago - Accesswire
}